Company Filing History:
1 out of 51 
1 out of 1,039 
Years Active: 2013
Title: The Innovative Contributions of Eric Hsi
Introduction
Eric Hsi is a notable inventor based in Orange Village, Ohio. He has made significant contributions to the field of medical research, particularly in the treatment of rare lymphomas. His work has the potential to impact the lives of many patients suffering from these conditions.
Latest Patents
Eric Hsi holds a patent for the "Use of anti-CS1 antibodies for treatment of rare lymphomas." This patent focuses on the applications of anti-CS1 antibodies, either alone or in combination with other agents, for treating rare lymphomas such as NK lymphomas, NK/T-cell lymphomas, and angioimmunoblastic lymphomas. He has 1 patent to his name, showcasing his innovative approach to addressing complex medical challenges.
Career Highlights
Throughout his career, Eric has worked with prominent organizations, including AbbVie Biotherapeutics Inc. and The Cleveland Clinic Foundation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Eric has collaborated with various professionals, including his coworker Daniel E. Afar. These partnerships have enhanced his research and development efforts, leading to advancements in the treatment of rare lymphomas.
Conclusion
Eric Hsi's contributions to medical research, particularly in the treatment of rare lymphomas, highlight his innovative spirit and dedication to improving patient outcomes. His work continues to inspire future advancements in the field.